Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational […]
In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic […]
For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have […]
The US Food and Drug Administration (FDA) is revoking the approval of Avastin® (bevacizumab) for the treatment breast cancer. The […]
As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including […]
As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer information throughout the year.
The View from the IVth Floor One woman shares some hard-won wisdom from years of living with metastatic cancer—and encourages […]
As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the […]
Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists […]
Cervical Cancer Survivors Face Risk of Second Cancers According to the results of a study presented at the 2007 annual […]
Hycamtin® Approved for Advanced Cervical Cancer According to a press release from GlaxoSmithKline, Hycamtin® (topotecan) was recently approved by the […]
Combination of Cisplatin and Topotecan Improves Survival in Advanced Cervical Cancer A phase III clinical trial published in the Journal […]
Stress and Depression Frequent Among Women Treated for Gynecological Cancers According to the results of a study recently published in […]
Addition of Taxol® to Cisplatin Improves Progression-Free Survival in Advanced Cervical Cancer According to a recent article published in the […]
Surgical Removal of Lung Metastases Improves Survival in Cervical Cancer According to a recent article published in the Annals of […]
Cisplatin Plus Topotecan Improves Survival Compared to Cisplatin Alone in Recurrent Cervical Cancer According to results presented at the 2004 annual meeting of the American Society of Gynecologic Oncologists, the chemotherapy combination consisting of cisplatin and topotecan improves survival compared to cisplatin alone in patients with recurrent or advanced cervical cancer. The cervix is a glandular organ that is located at the bottom of the uterus.